Volume 11, No 11 (2022)
Mini Review
COSTS INCURRED BY SUPPLY CHAINS AND DRUG RESISTANCE AS A RESULT OF TREATMENT HETEROGENEITY
Abstract HTML PDF
DOI: 10.37421/2277- 1506.2022.11.376
1-3
Mini Review
DRUG RESISTANCE MAY ACCELERATE AN HIV EPIDEMIC AS SHOWN BY THE NESTED MODEL
Abstract HTML PDF
DOI: 10.37421/2277- 1506.2022.11.377
1-4
Perspective
DRUG RESISTANCE, TUMOR CELL HETEROGENEITY AND EPIGENETIC MECHANISMS IN TUMORIGENESIS
HTML PDF
DOI: 10.37421/2277- 1506.2022.11.378
1-3
Opinion
FAILURE OF LYSOSOMOTROPIC DRUGS TO BE REPURPOSED FOR COVID-19 PREVENTION OR TREATMENT
HTML PDF
DOI: 10.37421/2277- 1506.2022.11.379
1-3
Commentary
RECENT HIGHLIGHTS IN RESISTANCE AND DRUG DEVELOPMENT AGAINST PROTOZOA
HTML PDF
DOI: 10.37421/2277- 1506.2022.11.380
1-3